Search
Search Results
-
Les temps forts de Chicago 2017
The annual meeting of the American Society of Clinical Oncology (ASCO), the largest international oncology congress, which was held at Chicago on...
-
Données en vie réelle de l’utilisation du trastuzumab IV dans le carcinome mammaire métastatique HER2-positif
With the arrival of fixed dose formulation in 2013 and biosimilars in the near future, we wanted to realize an inventory of the use of Trastuzumab IV...
-
Congrès l’association américaine de recherche contre le cancer — AACR 2017
The Annual American Association for Cancer Research (AACR) meeting for this year was took place at Washington, DC and over 21,900 participants from...
-
Carcinome hépatocellulaire : nouveautés épidémiologiques et démarche diagnostique
Hepatocellular carcinoma (HCC) occurs mainly on cirrhotic liver. Chronic viral infections B and C and excessive alcohol consumption remain the main...
-
Carcinome hépatocellulaire : résection ou transplantation hépatique ?
Hepatocellular carcinoma is the most common hepatic cancer and the frequency of its incidence is increasing. It develops from liver cirrhosis in 90%...
-
Traitements intra-artériels des carcinomes hépatocellulaires : évidence clinique et perspectives à venir
Intraarterial therapies such as transarterial chemoembolization and radioembolization have revolutionized the management of patients with...
-
Carcinome hépatocellulaire et traitements antiviraux contre le VHB et le VHC
Hepatitis B virus (HBV) treatment by nucleoside or nucleotide analog (NUC) and Hepatitis C virus (HCV) treatment by interferon-based therapy or by a...
-
Carcinome hépatocellulaire : nouveaux concepts, nouvelles molécules et nouvelles approches
Recent biological knowledge on hepatocellular carcinoma (HCC) has underlined the complexity of this malignant disease. The crucial role of tumor...
-
Carcinome hépatocellulaire : quels soins de confort ?
Palliative care must be proposed early to hepatocellular carcinoma patients due to the alteration brought about by the disease in the quality of...
-
Cancer de l’ovaire et inhibiteur de PARP : parcours des patientes en génétique oncologique
Ovarian cancer has poor prognosis: there are only a few medicated alternatives available for the new patients and the current treatments have limited...
-
Résistance primaire et résistance acquise aux inhibiteurs PD-1
Immunotherapy with PD-1/PD-L1 inhibitors is considered a revolutionary treatment of cancer. Initially used to treat melanoma with very encouraging...